Current Traditional Medicine covers all the aspects of the modernization and standardization research on the traditional medicine of the world, e.g., chemistry, pharmacology, molecular mechanism, systems biology, proteomics, genomics, metabolomics, safety, quality control, clinical studies of traditional Chinese, Ayurvedic, Unani, Arabic, and other ethnomedicine, and their practical use in the prevention and treatment of diseases. Each issue contains updated comprehensive, in-depth/mini-reviews along with high-quality original experimental research articles. Current Traditional Medicine is a leading and important international peer-reviewed journal reflecting the current outstanding scientific research progress of global traditional, indigenous, folk, and ethnologic medicine. Topics related to herbal medicine, manual wound healing methods, and other unconventional health care practices, such as acupuncture, homeopathy, naturopathy, are also included. It provides a bridge that connects the traditional medicine system to modern life science with the efforts of top scientists, as well as a resource to pursue the solutions for the existing common issues in traditional medicine. Read now: https://bit.ly/3darfHY
Science and technology on micro and nanoscales have been attracting great attention globally. Micro and Nanosystems provides a very fast and best forum for experimental and theoretical studies of fundamental and interdisciplinary research on micro and nanoscales. The emphasis is put on applications of micro and nanosystems to various different disciplines such as tissue engineering, medicine, energy, environment, food, and security. The topics on nanoimprint lithography, nano-reactor, molecular device, microfluidics, and MEMS are strongly welcome.
Micro and Nanosystems especially emphasizes on industrial and scalable methods for producing micro and nano scale materials and devices, pushing the technology from science to engineering. Read now:https://bit.ly/3Cc4vl0
Current Microwave Chemistryis an international peer-reviewed journal that publishes important contributions describing advances in the use of the microwave in the fields of chemistry, biology, medicine, biomedical science, and engineering. The journal covers microwave-assisted synthesis of novel organic, organometallic and inorganic molecules or complexes, kinetics and mechanistic studies of microwave-induced chemical reactions and potential use of microwave irradiation in the fields of drug discovery, green chemistry, catalysis and industrial process development. It is the premier source of microwave related information for chemists, biologists, pharmacologists and engineers in both industry and academia. Read Now: http://bit.ly/2kmlQSs
Volume 19, 3 Issues, 2022 ISSN: 1875-6913 (Online) ISSN: 1875-6921 (Print) This journal supports open access
Current Pharmacogenomics and Personalized Medicine (CPPM)is a transdisciplinary, peer-reviewed, biomedical journal that reports new findings and cutting-edge concepts in all areas of pharmacology. Special consideration is given to articles on pharmacogenomics and personalized medicine. CPPM is an accelerator for global personalized medicine and pharmacogenomics, as well as preclinical and clinical pharmacology. Importantly, the journal provides a multi-disciplinary, integrated platform from cell to society to address diagnostics and responsible pharmacogenomics applications in developing countries and the entire range of translational science from bench-to-bedside in various therapeutic areas such as oncology, cardiovascular, neuropharmacology, endocrine diseases, amongst others.
CPPM cooperates with the Ibero-American Network of Pharmacogenetics and the Pacific Rim Association for Clinical Pharmacogenetics and welcomes peer reviewed contributions from authors in any global region.
The journal’s scope is defined by four inter-connected aims. First, we are interested in genomics/postgenomics biotechnologies and diagnostics that enable global personalized medicine science (including and beyond pharmacogenomics), as long as they explain person-to-person and population differences in disease susceptibility or response to a health intervention, and can be substantiated. Second, we approach personalized medicine as ‘personalized health interventions’ focusing primarily on drug therapy, but also other interventions such as nutrition, vaccines, surgical devices, emerging cell-based therapies that collectively contribute to healthcare. Third, we strive to integrate molecular and clinical investigation with public policy, global health diplomacy and social studies of biotechnology, that collectively shape postgenomics future(s) and innovation trajectories in life sciences. Fourth, we are interested in all aspects of translational pharmacology from preclinical to clinical applications in any therapeutic area that will advance the practice of medicine for the benefit of patients worldwide including non-communicable diseases as well as infectious diseases in the post- COVID world.
Priority will be given to expert reviews/ mini-reviews and research articles that include original ideas and findings related to the scope and mandate of the journal. Unsolicited submissions are welcomed. Learn more: https://bit.ly/3ymTz1q
Bentham Science announces an important new multidisciplinary journal, Current Chinese Science. This will be the world’s largest journal with over 4,000 leading Chinese scientists involved on its editorial board.
Current Chinese Science is a peer reviewed journal with over 70 sections headed by leading Chinese scientists as Co-Editors. The journal will cover important and emerging fields in agriculture, science, engineering, medicine and other areas. The journal aims to provide researchers and scholars a strong platform to publish their work and share their findings with readers around the world. The Honorary Editors of the journal are Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-Ur-Rahman, FRS (Academician Chinese Academy of Sciences, and UNESCO Science Laureate).
The journal will be essential reading for scientists and scholars involved in a variety of scientific disciplines, largely reflecting the tremendous scientific progress being made in China. Every article in the first issue of Current Chinese Science will be published as Open Access (Free-to-download) for a limited time period of three months. Visit the journal website for further details: currentchinesescience.com
Extend the scope and visibility of your research by creating an animated abstract.
Bentham Science has collaborated with Focus Medica, one of the world’s largest publishers of expert animated atlases and videos in medicine and science.
An animated abstract will help summarise the essential discoveries/ key findings of your published research or review article. Each professionally produced full-coloured animated abstract in video format (length 3 – 5 minutes) is accompanied by an English spoken or foreign language commentary. The animated abstract will be published online along with the published article.
The payment for an animated abstract will be US$ 1400 for English language, and US$ 1900 for Foreign language articles. Initially, an advance payment of US$ 500 of the total payment will be payable to the Publisher to start work on the Animated Abstract, US$ 900 (English language) or US$ 1400 (Foreign language) will be payable on completion of the Animated Abstract.
Authors who opt for the “Animated Abstract” option and also wish to have their article made available on an “Open Access Plus” basis will be entitled to a 50% discount only on the Animated Abstract fee and, in addition, pay the normal Open Access Plus fee.
Authors will be asked whether they wish to opt-in for this paid service, and if not, the article will be published as normal. Animated abstracts are available as open access (free viewing) for maximum visibility and awareness to your readers at anytime, anywhere. The animated abstracts are licensed under the terms of the Creative Commons Attribution – NonCommercial-NoDerivatives 4.0 International Public License (CC BY-NC-ND 4.0) https://creativecommons.org/licenses/by-nc-nd/4.0/.
One of our animated abstracts can be viewed below:
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Author(s): Hannah Y. Mahmood, Shirin Jamshidi, J. Mark Sutton, Khondaker M. Rahman.
Antimicrobial resistance represents a significant challenge to future healthcare provision.An acronym ESKAPEE has been derived from the names of the organisms recognised as the major threats although there are a number of other organisms, notably Neisseria gonorrhoeae, that have become equally challenging to treat in the clinic. These pathogens are characterised by the ability to rapidly develop and/or acquire resistance mechanisms in response to exposure to different antimicrobial agents. A key part of the armoury of these pathogens is a series of efflux pumps, which effectively exclude or reduce the intracellular concentration of a large number of antibiotics, making the pathogens significantly more resistant. These efflux pumps are the topic of considerable interest, both from the perspective of basic understanding of efflux pump function, and its role in drug resistance but also as targets for the development of novel adjunct therapies. The necessity to overcome antimicrobial resistance has encouraged investigations into the characterisation of resistance-modifying efflux pump inhibitors to block the mechanisms of drug extrusion, thereby restoring antibacterial susceptibility and returning existing antibiotics into the clinic. A greater understanding of drug recognition and transport by multidrug efflux pumps is needed to develop clinically useful inhibitors, given the breadth of molecules that can be effluxed by these systems. This review discusses different bacterial EPIs originating from both natural source and chemical synthesis and examines the challenges to designing successful EPIs that can be useful against multidrug resistant bacteria. To know more about our Animated Abstract, please visit: http://www.eurekaselect.com/video.html
Current Nanosciencepublishes (a) Authoritative/Mini Reviews, and (b) Original Research and Highlights written by experts covering the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano-structures, nano-bubbles, nano-droplets and nanofluids. Applications of nanoscience in physics, material science, chemistry, synthesis, environmental science, electronics, biomedical nanotechnology, biomedical engineering, biotechnology, medicine and pharmaceuticals are also covered. The journal is essential to all researches involved in nanoscience and its applied and fundamental areas of science, chemistry, physics, material science, engineering and medicine.
Current Nanoscience also welcomes submissions on the following topics of Nanoscience and Nanotechnology:
Nanoelectronics and photonics
Nanofabrication and measurement
Nanobiotechnology and nanomedicine
Nanotechnology for energy
Sensors and actuator
Computational nanoscience and technology
Articles from the journal: Current Nanoscience; Volume 16 Issue 1
Current Bioinformaticsaims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science.
The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.
Bentham Science Publishers publishes over 140 scholarly journals (Subscription based and Open Access) related to various subject areas of science, technology and medicine. The journals are indexed, recognized and associated with reputable scientific agencies, directories and other entities.
Each article submitted to Bentham Science journals (Subscription and Open Access) is rigorously peer-reviewed. You can read more about our peer review process here. Bentham’s publications are also part of COPE, an organization that aims to define best practice in the ethics of scholarly publishing and to assist authors, editors and publishers to achieve the defined standards. We have several notable journals included in the Journal Citation Reports of Clarivate Analytics with Impact Factor rankings.
The article published in Springer, Medicine, Health Care and Philosophy, that discusses predatory publishing, highlighted a link from a controversial list by Jeffery Beall which has been taken down due to its controversial nature. However, even if one considers his list, he had included publishers such as Biomed Central (part of the Springer-Nature group), Frontier Science etc., all of which are thoroughly respected and reputable publishers. This does not mean that those 2 publishers are predatory, and the same rule applies here. Bentham Science has promptly and clearly addressed all allegations in the past, of any predatory practices, and has duly satisfied its stakeholders and maintained their trust and association. Repetition of such claims is false and misleading. To read the full blog, please visit: https://bit.ly/2HkozFU